Today it was announced that Andreas Weber has been appointed CEO of EvidentIQ, the newly formed life science group from the merger of clinical software vendors XClinical and Fortress Medical with social platform Carenity.
The company said Weber brings more than 20 years of industry experience after management positions at ERT, Bioclinica and Oracle Health Sciences.
The EvidentIQ offering brings an end-to-end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs with its suite of applications, including EDC, coding, remote monitoring, RBM ePRO, eTMF, CTMS, RTMS, Payments and eFeasibility within a single integrated cloud platform. By combining the platform with a broad data science service portfolio such as patient recruitment, patient engagement media and a host of RWE late phase solutions EvidentIQ significantly helps customers optimize HTA submissions, pricing and reimbursement needs.
In a statement on the new company name and future positioning of the group, Weber said: “By evolving into a next generation technology-amplified data science group, EvidentIQ is paving the way for a new standard in value creation and innovation driven relevance for its customers. Our customers across XClinical, Carenity and Fortress Medical are at the heart of everything we do. As such, I wanted to assure our current loyal and valued customers, that not only will we continue the existing solutions and support offerings, we will in fact be expanding them technologically as well as increasing their interoperability.”
Seconding Mr. Weber, Lewis Baird will manage sales as chief commercial officer. Before joining EvidentIQ, Lewis established and led the European commercial team at Medrio after holding commercial leadership roles at DataTrial, Biorasi and Quintiles.
Together with Manuel Neukum (Chief Operations Officer), Michael Chekroun (Chief Strategy and Transformation Officer) and Roland Hiltmann (Chief Financial Officer), Lewis is part of Andreas Weber’s Executive Management Team.
Today EvidentIQ supports 7 of the top 10 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.
